A Community in Unity

Publication
Article
Oncology & Biotech NewsApril 2015
Volume 9
Issue 4

The Emperor of All Maladies documentary did a great job of capturing the innovative genius of mankind and the heroism of both oncologists and the patients who participated in their research.

OncLive Chairman,

Mike Hennessy

The Emperor of All Maladies

documentary did a great job of capturing the innovative genius of mankind and the heroism of both oncologists and the patients who participated in their research. There has certainly been a miraculous evolution in cancer care, from nearly uniform hopelessness to genetically targeted treatments that in some cases, eradicate the disease.

The film was not just inspirational for the story it told, but also for the reaction it generated in the oncology community. Each of the 3 nights it aired, social media lit up with enthusiastic tweets from patients, caregivers, family members, and even those who were learning the story of oncology for the first time. Several oncologists even tweeted that it felt as though they were viewing the film together with their colleagues in their living room.

genetics

epigenetics

precision medicine

collaboration

team science

multidisciplinary

It is this communal effort, this unified front in the oncology community, that will lay the foundation to forge continued advancement in cancer care. Keywords in the next chapter in oncology will not only be , , and , but also , , and .

OncLive

Oncology & Biotech News

OncLive Peer Exchange

War on Cancer

Cancers

Indeed, the motto of , the network that houses is “Bringing the Oncology Community Together.” We understand the significance of collaboration and promote interaction through our affiliate’s scientific meetings (GoToPER.com), our panels (onclive.com/peer-exchange), and several other platforms. Progress in the , or more appropriately, , requires a unified effort among caregivers, patients, researchers, industry, regulators, and donors.

The Emperor of All Maladies

Emperor

Fortunately, what experience has demonstrated is that we are “a community in unity.” Now, we must sustain this spirit to evolve beyond the history that was so eloquently captured in the film. I have full faith in our limitless capacity to do just that. As author Siddhartha Mukherjee, MD, PhD, concluded in the film’s final words, “If the cancer cell is evolving, then so are we.”

Related Videos
Arya Amini, MD
Adrianna Masters, MD, PhD,
Chul Kim, MD, MPH
Andrew Ip, MD
In this final episode of OncChats: Assessing the Promise of AI in Oncology, Toufic A. Kachaamy, MD, and Douglas Flora, MD, LSSBB, FACCC, discuss a roadmap of artificial intelligence (AI) advances in the next 5 to 10 years.
In this eighth episode of OncChats: Assessing the Promise of AI in Oncology, Toufic A. Kachaamy, MD, and Douglas Flora, MD, LSSBB, FACCC, explain how artificial intelligence tools are being developed to match the right patient to the right drug on the right clinical trial.
In this seventh episode of OncChats: Assessing the Promise of AI in Oncology, Toufic A. Kachaamy, MD, and Douglas Flora, MD, LSSBB, FACCC, discuss how artificial intelligence tools may be utilized to improve wait time for treatment, to provide more time for provider-patient interactions, and more.
In this final episode of OncChats: Reviewing Best Practices in the Surgical Management of Breast Cancer, Gladys Giron, MD, FACS, and Cristina Lopez-Peñalver, MD, shed light on clinical outcomes following surgery of the primary tumor in patients with stage IV breast cancer.
In this sixth episode of OncChats: Assessing the Promise of AI in Oncology, Toufic A. Kachaamy, MD, and Douglas Flora, MD, LSSBB, FACCC, discuss potential opportunities to leverage artificial intelligence tools in cancer screening, diagnosis, staging, and prognosis.
Christopher M. Gallagher, MD